My research agenda is built on empirically understanding how firms may manage, and make better decisions, in the face of risks which threaten to disrupt critical organizational processes: from the loss of value due to the information asymmetries and uncertainties between supply chain partners, to the wrong investments in a pharmaceutical firm’s portfolio of drug development projects.

Project Selection and Success: Insights from the Drug Development Process - with S. Kavadias and N. Oraiopoulos [Link to SSRN]

  • Winner 2018 INFORMS TIMES Best Working Paper Award

Information Asymmetry, Rents, and Cost Risk Allocation: An Investigation of the BMW Supply Chain -

with D. Turcic, P. Kouvelis, and D. Corsten [Link to SSRN]

Collateral, Risk, and Borrowing Capacity - with R. Williams and J. Yang [Link to SSRN]

  • Finalist 2018 Financial Management Association (FMA) Best Paper Award

Suppliers as Liquidity Insurers - with D. Corsten and R. Gropp [Link to SSRN]

Financial and Operational Risk Management: Inventory Effects in the Gold Mining Industry - with D. Corsten [Link to SSRN]